Curious about how mRNA vaccines and other types of COVID-19 vaccines can help you develop immunity to the COVID-19 virus? Understand how different technologies work with the immune system to provide protection.
Feb 12, 2021
0
15
As Australia strives to reach its national COVID vaccination targets, there's unprecedented focus on the biological effects of vaccines.
Oct 8, 2021
0
10
(Medical Xpress)—Published online in the prestigious Proceedings of the National Academy of Sciences (PNAS), the team from CSIRO's Australian Animal Health Laboratory, in Geelong, have shown Vago, a protein previously identified ...
Oct 3, 2012
0
0
A Western University team's novel approach to developing a COVID-19 vaccine shows promise in inducing a robust immune response, early data shows.
Dec 20, 2021
0
41
(Medical Xpress)—A large team of researchers from the U.S. and Canada has conducted a randomized double-blind study of the effectiveness of an HIV vaccine and has found it to be ineffective in suppressing the virus. In ...
Researchers at Mount Sinai School of Medicine have found in a Phase II trial that a gene therapy developed at Mount Sinai stabilized or improved cardiac function in people with severe heart failure. Patients receiving a high ...
Jun 28, 2011
0
0
The lone volunteer in a gene-editing study targeting a rare form of Duchenne muscular dystrophy likely died after having a reaction to the virus that delivered the therapy in his body, researchers concluded in an early study.
Jun 1, 2023
0
38
Patients with tuberous sclerosis complex, a genetic disorder characterized by the growth of noncancerous tumors in multiple organs of the body, have limited treatment options. A team led by investigators at Massachusetts ...
Jan 9, 2021
0
124
The first three coronavirus vaccines earned Emergency Use Authorization more than a year ago. To date, no other vaccines have been put into use in the U.S—but that will soon change. More than 40 vaccines are undergoing ...
May 5, 2022
0
119
Scientists at the Howard Hughes Medical Institute's Janelia Research Campus and the University of California, Berkeley have developed a powerful new tool for neuroscientists—a viral vector called rAAV2-retro, which efficiently ...
Oct 7, 2016
0
55
